R-GemOx

From OncoWiki
Revision as of 02:18, 7 February 2012 by Palmdoc (talk | contribs) (1 revision)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Regimen

Rituximab (Rituxan) 375 mg/m2 iv d1
Gemcitabine (Gemzar) 1000 mg/m2 (in 500 ml normal saline) iv at 10 mg/m2/min d2
Oxaliplatin 100 mg/m2 iv over 2 hrs d2
Q2w x 8 cycles
  • Rituxan is a monoclonal antibody.
  • Rituxan Use and Side Effects Information

References

Gnaoui TE et al. Rituximab, gemcitabine and oxaliplatin: an effective salvage regimen for patients with relapsed or refractory B-cell lymphoma not candidates for high-dose therapy. Ann Oncol 2007; Advanced access published May 11, 2007

Retrieved from "http://oncowiki.info/index.php?title=R-GemOx&oldid=577"